The new trial, funded by Pfizer, compared the company’s mRNA shot to Fluzone, one of the most widely used seasonal flu ...

The mRNA platform offers the advantage of faster vaccine production, which could allow more time to decide on which flu strains to cover.

For people younger than 65, U.S.-licensed flu vaccines had an estimated effectiveness of 44% to 54% that season. Among those who completed a 6-month follow-up, the mRNA vaccine had a relative efficacy ...

Moderna said on Wednesday it would now operate full end-to-end manufacturing for its mRNA medicines in the U.S., marking a major step in strengthening the company's domestic production network.

Moderna (MRNA) stock is in focus as the company completes U.S. mRNA production network, investing $140M in Massachusetts and ...

People with ties to Brownstone Institute have significant authority over access to vaccines and scientific research.

His institute’s covid contrarians seek to limit the government’s role in protecting Americans from disease. The Austin, Texas ...

The global lidocaine market, valued at approximately USD 0.89 billion in 2023, is projected to expand at a compound annual growth rate (CAGR) of 5.26% over the forecast period from 2024 to 2032.